Unknown

Dataset Information

0

Combination strategies enhance oncolytic virotherapy.

ABSTRACT:

SUBMITTER: Friedman GK 

PROVIDER: S-EPMC5470943 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Combination strategies enhance oncolytic virotherapy.

Friedman Gregory K GK   Markert James M JM   Gillespie George Yancey GY  

Oncotarget 20170501 21

Similar Datasets

Unknown Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy.
| S-EPMC5459877 | biostudies-literature
Unknown Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma.
| S-EPMC7723446 | biostudies-literature
Unknown Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma.
| S-EPMC10889383 | biostudies-literature
Unknown Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy.
| S-EPMC3584319 | biostudies-literature
Unknown Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy.
| S-EPMC7882891 | biostudies-literature
Unknown Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches.
| S-EPMC9504140 | biostudies-literature
Unknown Oncolytic virotherapy as immunotherapy.
| S-EPMC8961675 | biostudies-literature
Unknown Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.
| S-EPMC7978281 | biostudies-literature
Unknown Combination with oxaliplatin improves abscopal effect of oncolytic virotherapy through reorganization of intratumoral macrophages.
| S-EPMC11764124 | biostudies-literature
Unknown The Combination of TIM3-Based Checkpoint Blockade and Oncolytic Virotherapy Regresses Established Solid Tumors.
| S-EPMC9783015 | biostudies-literature